Hudson Canyon Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Buy |
3,440
+343
| +11% | +$139K | 0.87% | 51 |
|
|
2025
Q1 | $1.54M | Hold |
3,097
| – | – | 1.09% | 48 |
|
|
2024
Q4 | $1.61M | Hold |
3,097
| – | – | 1.05% | 47 |
|
|
2024
Q3 | $1.92M | Hold |
3,097
| – | – | 1.24% | 38 |
|
|
2024
Q2 | $1.71M | Sell |
3,097
-380
| -11% | -$210K | 1.16% | 37 |
|
|
2024
Q1 | $2.02M | Hold |
3,477
| – | – | 1.3% | 35 |
|
|
2023
Q4 | $1.85M | Sell |
3,477
-77
| -2% | -$40.9K | 1.34% | 39 |
|
|
2023
Q3 | $1.8M | Hold |
3,554
| – | – | 1.47% | 29 |
|
|
2023
Q2 | $1.85M | Sell |
3,554
-112
| -3% | -$58.4K | 1.46% | 29 |
|
|
2023
Q1 | $2.11M | Sell |
3,666
-159
| -4% | -$91.6K | 1.77% | 15 |
|
|
2022
Q4 | $2.11M | Sell |
3,825
-83
| -2% | -$45.7K | 1.94% | 12 |
|
|
2022
Q3 | $1.98M | Hold |
3,908
| – | – | 1.97% | 15 |
|
|
2022
Q2 | $2.12M | Buy |
3,908
+41
| +1% | +$22.3K | 2.05% | 11 |
|
|
2022
Q1 | $2.28M | Hold |
3,867
| – | – | 1.8% | 16 |
|
|
2021
Q4 | $2.58M | Sell |
3,867
-376
| -9% | -$251K | 1.87% | 10 |
|
|
2021
Q3 | $2.42M | Sell |
4,243
-157
| -4% | -$89.7K | 1.87% | 13 |
|
|
2021
Q2 | $2.22M | Buy |
+4,400
| New | +$2.22M | 1.66% | 24 |
|